• Latest
  • Trending
  • All
  • News
  • Business
  • Lifestyle
US Near Authorization of Johnson & Johnson COVID-19 Vaccine

J&J COVID-19 Vaccine Shipping to US, but New Deliveries Hinge on Regulators

March 1, 2021
Some Chicago Dems Clamoring For Ex-Con To Run For Congress Again

Some Chicago Dems Clamoring For Ex-Con To Run For Congress Again

July 8, 2025
DANIEL MCCARTHY: Democrats Need Populism, But Not Zohran’s Sort

DANIEL MCCARTHY: Democrats Need Populism, But Not Zohran’s Sort

July 8, 2025
Reporter Asks Pam Bondi About Missing Minute In Epstein Jail Footage

Reporter Asks Pam Bondi About Missing Minute In Epstein Jail Footage

July 8, 2025
DeSantis, Harris Volley Jabs Over Hurricane Milton: ‘It’s Not About You, Kamala’

DeSantis to Musk: America Party Not the Answer

July 8, 2025
‘Who The Hell Does He Think He Is?’: JD Vance Blasts Mamdani For His Disrespectful Tone Toward US

‘Who The Hell Does He Think He Is?’: JD Vance Blasts Mamdani For His Disrespectful Tone Toward US

July 8, 2025
Key GOP-Aligned War Chest Overflowing With Cash As Midterms Loom

Key GOP-Aligned War Chest Overflowing With Cash As Midterms Loom

July 8, 2025
Trump Admin Moves To Block China From Grabbing Up American Farmland

Trump Admin Moves To Block China From Grabbing Up American Farmland

July 8, 2025
Biden Admin Paroled Thousands Of Migrants Into US Without Any Plan To Return Them Home

Biden Admin Paroled Thousands Of Migrants Into US Without Any Plan To Return Them Home

July 8, 2025
Rubio Announces Release of American Former Ballerina From Russian Prison

Report: Imposter Poses as Rubio Using AI

July 8, 2025
Trump To Send Portion Of Key Missile Shipment To Ukraine

Trump To Send Portion Of Key Missile Shipment To Ukraine

July 8, 2025
Feds Throw Book At Armed Leftists Arrested In Texas ICE ‘Ambush’ Attack

Feds Throw Book At Armed Leftists Arrested In Texas ICE ‘Ambush’ Attack

July 8, 2025
Elite College Says It Will No Longer Appease Pro-Hamas Protesters

Elite College Says It Will No Longer Appease Pro-Hamas Protesters

July 8, 2025
  • Donald Trump
  • State of the Union
  • Elon Musk
  • Tariffs
  • Congress
  • Faith
  • Immigration
Tuesday, July 8, 2025
  • Login
IJR
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls
No Result
View All Result
IJR
No Result
View All Result
Home News

J&J COVID-19 Vaccine Shipping to US, but New Deliveries Hinge on Regulators

by Reuters
March 1, 2021 at 4:47 pm
in News
240 12
0
US Near Authorization of Johnson & Johnson COVID-19 Vaccine

A lab worker holds a vial of Johnson & Johnson's Janssen coronavirus disease (COVID-19) vaccine candidate in an undated photograph. Johnson & Johnson/Handout via REUTERS.

491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

Johnson & Johnson will ship nearly 4 million doses of its newly authorized single-dose COVID-19 vaccine around the United States this week, but a top executive said on Monday that the next round of deliveries is contingent on regulatory approvals at a new plant.

The drugmaker expects to deliver another 16 million doses of the vaccine by the end of this month. But none is expected to go out next week.

“Four million doses are already on trucks to different places in the U.S.,” J&J Chief Scientific Officer Paul Stoffels said in an interview, noting that those doses came from a smaller plant already up and running.

He said a new, larger plant operated by contract manufacturer Catalent Inc has been preparing doses, but the U.S. Food and Drug Administration (FDA) still needs to allow the companies to begin shipping them.

“The FDA is looking at all the quality data and, hopefully, very quickly we’ll be able to get approval to ship from that plant and then we get going.”

Stoffels said he expects the Catalent plant to receive approval in the next few days and the company would be able to meet its promise to supply 20 million doses of the vaccine by the end of March.

Catalent said it may take a bit longer.

“Catalent is on track to deliver on our commitments for Johnson & Johnson COVID-19 vaccine deliveries as soon as we are approved to begin shipments by the FDA, which we anticipate in the coming weeks,” Mike Riley, president for Catalent North America, said in a statement.

SHOTS IN ARMS

J&J Chief Executive Office Alex Gorsky said in an interview with NBC News’ “Today” program that Americans should begin getting his company’s shot on Tuesday or Wednesday.

“Within the next 24 to 28 hours, Americans should start receiving shots in arms,” he told NBC News.

The coronavirus has been circulating for more than a year, and in recent months new virus variants have arisen against which the J&J vaccine and others appear less effective. Public health officials say a global vaccination effort can help stem these variants from developing.

Gorsky said J&J was confident that its vaccine would have a “robust response” against these emerging variants, based on its clinical trials in countries including South Africa and Brazil where worrisome variants were circulating.

The company is developing a version of its vaccine to target the variant first found in South Africa, and will be ready to start late-stage trials by this summer.

Pfizer and German partner BioNTech and Moderna Inc have FDA-authorized two-dose vaccines.

Shares of J&J closed up 0.6% at $159.39. The FDA gave it emergency use authorization on Saturday.

McKesson Corp said on Monday it had begun distributing the vaccine.

(Reporting by Susan Heavey in Washington, Michael Erman in New York, Julie Steenhuysen in Chicago and Manas Mishra in Bengaluru; Editing by Toby Chopra, Bernadette Baum, Maju Samuel and Jonathan Oatis)

Tags: Coronavirus Outbreak
Share196Tweet123
Reuters

Reuters

Reuters is an international news organization.

Advertisements

Top Stories June 10th
Top Stories June 7th
Top Stories June 6th
Top Stories June 3rd
Top Stories May 30th
Top Stories May 29th
Top Stories May 24th
Top Stories May 23rd
Top Stories May 21st
Top Stories May 17th

Join Over 6M Subscribers

We’re organizing an online community to elevate trusted voices on all sides so that you can be fully informed.





IJR

    Copyright © 2024 IJR

Trusted Voices On All Sides

  • About Us
  • GDPR Privacy Policy
  • Terms of Service
  • Editorial Standards & Corrections Policy
  • Subscribe to IJR

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls

    Copyright © 2024 IJR

Top Stories June 10th Top Stories June 7th Top Stories June 6th Top Stories June 3rd Top Stories May 30th Top Stories May 29th Top Stories May 24th Top Stories May 23rd Top Stories May 21st Top Stories May 17th